Screener
Novavax NVAX Total Cost of Revenue
Total Cost of Revenue at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Novavax in its filing.
Tagged under the XBRL concept us-gaap:CostOfRevenue.
The source filing: Novavax’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 7:50 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001000694-26-000018
| Line item | For the Three Months Ended June 30, 2026 | For the Three Months Ended June 30, 2025 | For the Six Months Ended June 30, 2026 | For the Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Licensing, royalties, and other | 37,844 | 228,516 | 135,158 | 273,493 |
| Total revenue | 56,698 | 239,240 | 196,212 | 905,895 |
| Expenses: | ||||
| Cost of sales | 14,246 | 15,325 | 44,941 | 29,439 |
| Research and development | 70,693 | 79,233 | 166,165 | 168,170 |
| Selling, general, and administrative | 26,665 | 43,612 | 55,442 | 91,702 |
| Total expenses | 111,604 | 138,170 | 266,548 | 289,311 |
| Income (loss) from operations | (54,906) | 101,070 | (70,336) | 616,584 |
Item 1. Consolidated Financial Statements
FAQ
- What is Novavax's total cost of revenue?
- Novavax (NVAX) reported total cost of revenue of $14.25M in Q2 2026.
- How has Novavax's total cost of revenue changed year-over-year?
- Novavax's total cost of revenue decreased by 7.0% year-over-year, from $15.33M to $14.25M.
- What does total cost of revenue mean?
- The aggregate of all direct costs attributable to producing goods and delivering services that generated the company's revenue, including materials, labor, and overhead.
Ask your AI about Novavax's total cost of revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude